Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 12, 2008, Pages 1591-1600

  Gordon, Sarah ^a   Saupe, Anne ^a   McBurney, Warren ^a   Rades, Thomas ^a   Hook, Sarah ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CHITOSAN; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G; NANOPARTICLE; OVALBUMIN; VACCINE;

ADOPTIVE TRANSFER; ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GELATION; HYDROGEL; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE FORMULATION; T LYMPHOCYTE ACTIVATION; VISCOSITY; ZETA POTENTIAL;

EID: 56849095759     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.12.0004     Document Type: Article

References (56)

1. Agnihotri, S. A., Mallikarjuna, N. N., Aminabhavi, T. M. (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 100: 5-28
2. Amidi, M., Romeijn, S. G., Borchard, G., Junginger, H. E., Hennink, W. E., Jiskoot, W. (2006) Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J. Control. Release 111: 107-116
3. Avramidis, N., Victoratos, P., Yiangou, M., Hadjipetrou-Kourounakis, L. (2002) Adjuvant regulation of cytokine profile and antibody isotype of immune responses to Mycoplasma agalactiae in mice. Vet. Microbiol. 88: 325-338
4. Barnden, M. J., Allison, J., Heath, W. R., Carbone, F. R. (1998) Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40
5. Berger, J., Reist, M., Chenite, A., Felt-Baeyens, O., Mayer, J. M., Gurny, R. (2005) Pseudo-thermosetting chitosan hydrogels for biomedical application. Int. J. Pharm. 288: 197-206
6. Bramwell, V. W., Perrie, Y. (2005) Particulate delivery systems for vaccines. Crit. Rev. Ther. Drug Carrier Syst. 22: 151-214
7. Chae, S. Y., Jang, M.-K., Nah, J.-W. (2005) Influence of molecular weight on oral absorption of water soluble chitosans. J. Control. Release 102: 383-394
8. Cho, J., Heuzey, M.-C., Begin, A., Carreau, P. J. (2005) Physical gelation of chitosan in the presence of β-glycerophosphate: the effect of temperature. Biomacromolecules 6: 3267-3275
9. Clements, C. J., Larsen, G., Jodar, L. (2004) Technologies that make administration of vaccines safer. Vaccine 22: 2054-2058
10. Demana, P. H., Davies, N. M., Hook, S., Rades, T. (2005) Quil A-lipid powder formulations releasing ISCOMs and related colloidal stuctures upon hydration. J. Control. Release 103: 45-59
11. Dufes, C., Muller, J.-M., Couet, W., Olivier, J.-C., Uchegbu, I. F., Schätzlein, A. G. (2004) Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharm. Res. 21: 101-107
12. Foged, C., Brodin, B., Frokjaer, S., Sundblad, A. (2005) Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int. J. Pharm. 298: 315-322
13. Gupta, R. K. (1998) Aluminum compounds as vaccine adjuvants. Adv. Drug Deliv. Rev. 32: 155-172
14. Gupta, P., Vermani, K., Garg, S. (2002) Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov. Today 7: 569-579
15. Han, L-K., Kim, Y. B., Kang, H.-S., Sul, D., Jung, W.-W., Cho, H. J., Oh, Y.-K. (2006) Thermosensitive and mucoadhesive delivery systems of mucosal vaccines. Methods 38: 106-111
16. Ishihara, M., Obara, K., Nakamura, S., Fujita, M., Masuoka, K., Kanatani, Y., Takase, B., Hattori, H., Morimoto, Y., Ishihara, M., Maehara, T., Kikuchi, M. (2006) Chitosan hydrogel as a drug delivery carrier to control angiogenesis. J. Artif. Organs 9: 8-16
17. Jeong, B., Lee, K. M., Gutowska, A., An, Y. H. (2002) Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering. Biomacromolecules 3: 865-868
18. Kayser, O., Olbrich, C., Croft, S. L., Kiderlen, A. F. (2003) Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs. Parasitol. Res. 90: S63-S70
19. Kofuji, K., Akamine, H., Qian, C. J., Watanabe, K., Togan, Y., Nishimura, M., Sugiyama, I., Murata, Y., Kawashima, S. (2004) Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation. Int. J. Pharm. 272: 65-78
20. Könnings, S., Copland, M. J., Davies, N. M., Rades, T. (2002) A method for the incorporation of ovalbumin into immune stimulating complexes prepared by the hydration method. Int. J. Pharm. 241: 385-389
21. Köping-Höggård, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Varum, K., Artursson, P. (2001) Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 8: 1108-1121
22. Kreuter, J. (1996) Nanoparticles and microparticles for drug and vaccine delivery. J. Anat. 189: 503-505
23. Lofthouse, S. (2002) Immunological aspects of controlled antigen delivery. Adv. Drug Deliv. Rev. 54: 863-870
24. Lopez-Leon, T., Carvalho, E. L. S., Seijo, B., Ortega-Vinuesa, J. L., Bastos-Gonzalez, D. (2005) Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J. Colloid Interface Sci. 283: 344-351
25. Luzardo-Alvarez, A., Blarer, N., Peter, K., Romero, J. F., Reymond, C., Corradin, G., Gander, B. (2005) Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice. J. Control. Release 109: 62-76
26. Mao, J., Kondu, S., Ji, H.-F., McShane, M. J. (2006) Study of the near-neutral pH-sensitivity of chitosan/gelatin hydrogels by turbidimetry and microcantilever deflection. Biotechnol. Bioeng. 95: 333-341
27. Mi, F.-L., Shyu, S.-S., Wong, T.-B., Jang, S.-F., Lee, S.-T., Lu, K.-T. (1999) Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. II. Effect of pH-dependent ionic crosslinking or interpolymer complex using tripolyphosphate or polyphosphate as reagent. J. Appl. Polym. Sci. 74: 1093-1107
28. Mohammed, A. R., Bramwell, V. W., Coombes, A. G. A., Perrie, Y. (2006) Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products. Methods 40: 30-38
29. Myschik, J., McBurney, W. T., Hennessy, T., Phipps-Green, A., Rades, T., Hook, S. (2008) Immunostimulatory biodegradable implants containing the adjuvant Quil-A - Part II: in vivo evaluation. J. Drug Target. 16: 224-232
30. Nagamoto, T., Hattori, Y., Takayama, K., Maitani, Y. (2004) Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm. Res. 21: 671-674
31. Obara, K., Ishihara, M., Ozeki, Y., Ishizuka, T., Hayashi, T., Nakamura, S., Saito, Y., Yura, H., Matsui, T., Hattori, H., Takase, B., Ishihara, M., Kikuchi, M., Maehara, T. (2005) Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J. Control. Release 110: 79-89
32. O'Hagan, D. T., MacKichan, M. L., Singh, M. (2001) Recent developments in adjuvants for vaccines against infectious diseases. Biomol. Eng. 18: 69-85
33. Paster, W., Kalat, M., Zehetner, M., Schweighoffer, T. (2002) Structural elements of a protein antigen determine immunogenicity of the embedded MHC class I-restricted T cell epitope. J. Immunol. 169: 2937-2946
34. Perrie, Y., Barralet, J. E., McNeil, S., Vangala, A. (2004) Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route. Int. J. Pharm. 284: 31-41
35. Pinto Reis, C., Neufeld, R. J., Ribeiro, A. J., Veiga, F. (2006) Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine 2: 53-65
36. Porporatto, C., Bianco, I. D., Correa, S. G. (2005) Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration. J. Leukoc. Biol. 78: 62-69
37. Prego, C., Garcia, M., Torres, D., Alonso, M. J. (2005) Transmucosal macromolecular drug delivery. J. Control. Release 101: 151-162
38. Qin, C., Gao, J., Wang, L., Zeng, L., Liu, Y. (2006) Safety evaluation of short-term exposure to chitooligomers from enzymic preparation. Food Chem. Toxicol. 44: 855-861
39. Read, R. C., Naylor, S. C., Potter, C. W., Bond, J., Jabbal-Gill, I., Fisher, A., Ilium, L., Jennings, R. (2005) Effective nasal influenza vaccine delivery using chitosan. Vaccine 23: 4367-4374
40. Ruel-Gariépy, E., Chenite, A., Chaput, C., Guirguis, S., Leroux, J.-C. (2000) Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int. J. Pharm. 203: 89-98
41. Saupe, A., McBurney, W., Rades, T., Hook, S. (2006) Immunostimulatory colloidal delivery systems for cancer vaccines. Expert Opin. Drug Deliv. 3: 345-354
42. Seferian, P. G., Martinez, M. L. (2001) Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine 19: 661-668
43. Shu, X. Z., Zhu, K. J. (2000) A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int. J. Pharm. 201: 51-58
44. Silva, S. S., Santos, M. I., Coutinho, O. P., Mano, J. F., Reis, R. L. (2005) Physical properties and biocompatibility of chitosan/soy blended membranes. J. Mater. Sci. Mater. Med. 16: 575-579
45. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., Rudzinski, W. E. (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70: 1-20
46. Subramanian, A., Hommerding, J. (2005) The use of confocal laser scanning microscopy to study the transport of biomacromolecules in a macroporous support. J. Chromatogr. B 818: 89-97
47. Tuma, R. (2005) Raman spectroscopy of proteins: from peptides to large assemblies. J. Raman Spectrosc. 36: 307-319
48. Ulbrandt, N. D., Cassatt, D. R., Patel, N. K., Roberts, W. C., Bachy, C. M., Fazenbaker, C. A., Hanson, M. S. (2001 ) Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies. Infect. Immun. 69: 4799-4807
49. Vangala, A., Bramwell, V. W., McNeil, S., Christensen, D., Agger, E. M., Perrie, Y. (2007) Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. J. Control. Release 119: 102-110
50. Vila, A., Sanchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J. L. V., Alonso, M. J. (2004) Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur. J. Pharm. Biopharm. 57: 123-131
51. Wang, W. (1999) Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185: 129-188
52. White, K., Rades, T., Kearns, P., Toth, I., Hook, S. (2006) Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm. Res. 23: 1473-1481
53. Yamasaki, M., Takahashi, N., Hirose, M. (2003) Crystal structure of S-ovalbumin as a non-loop-inserted thermostabilized serpin form. J. Biol. Chem. 278: 35524-35530
54. Zaharoff, D. A., Rogers, C. J., Hance, K. W., Schlom, J., Greiner, J. W. (2007) Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 25: 2085-2094
55. Zhao, Z., Leong, K. W. (1996) Controlled delivery of antigens and adjuvants in vaccine development. J. Pharm. Sci. 85: 1261-1270
56. Zinkernagel, R. M., Ehl, S., Aichele, P., Oehen, S., Kündig, T., Hengartner, H. (1997) Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156: 199-209